Healthcare and Life Science
New app helps midwives spot health issues at birth
Digital resource provides important information to students and healthcare staff
Medical Affairs Professional Society (MAPS) 2023 EMEA Annual Meeting
The MAPS 2023 EMEA Annual Meeting is taking place in Lisbon, Portgual, May 14-16, 2023. We invite you to be part of THE defining moment for Medical Affairs as we fully realize our place as a strategic pillar in the biopharmaceutical and MedTech industries. ...
An analysis of obesity diagnosis and treatment in Medicare and the associated policy landscape
Obesity is a common, serious, and costly disease that increases people’s risk for morbidity and mortality.[1] It is characterized by abnormal or excessive body fat accumulation; weight loss and lifestyle changes have been shown to reduce the risk for associated negative health outc...
Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples ...
Guardtech Group escalating digital presence with latest series of new websites
Cleanroom construction specialists have plans to unveil at least three more new sites after CleanCube and Cleanroom Solutions launches ...
Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Kenneth Hitchner, BA MBA, as Chairman of its Board of Directors. The announcement follows a series of appointments to the Company’...
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the first patient has been dosed in the US under its Investigational New Drug (IND) Application in Avacta’s phase 1 multi-centre trial evaluating...
US patent granted protecting proprietary formulations of monoclonal antibodies
Endorses potential of proprietary Arestat™ platform technology to invent novel, enhanced therapeutics in $210 billion monoclonal antibody market Further strengthens Group’s extensive patent portfolio Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’...
Will the PSTN switch-off affect your business or school?
In December 2025, phone lines in the UK will go fully digital, and the remaining analogue phone lines – the Public Switch Telephone Network (PSTN) – will be permanently switched off. ...
Cresset appoints first Chief Financial Officer
As a consequence of recent investment from Scottish Equity Partners, we are delighted to welcome John Leighton to the Board and Executive Management team. ...